Zinzino AB (publ.) has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company’s distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Sanki’s subsidiaries in Colombia and Peru are being acquired to accelerate the establishment processes and increase distribution power in those countries.
The acquisition of Sanki adds increased distribution power in combination with an innovative, trademarked product portfolio, tailored to be integrated into Zinzino‘s test-based product concept.
The asset acquisition is also another strategically important step in Zinzino‘s growth plans, with a focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.
Sanki is a direct sales company in the health segment, operating in North America (USA and Mexico) and South America (Colombia and Peru). Its brand portfolio offers a range of innovative and patented products in the field of health and well-being. The business has a total annual turnover of approximately USD 12 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with the integration of Sanki’s product portfolio into